Reducing Risk for Thrombosis in Patients With Lung Cancer Reducing Risk for Thrombosis in Patients With Lung Cancer

Researchers have examined whether treatment with lazertinib-amivantamab entails an increased risk of venous thromboembolism in patients with advanced or metastatic non –small cell lung cancer.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news